Quotes 5-day view Delayed Nasdaq
Estimated financial data (e) (USD)
Net income 2021
Net Debt 2021
P/E ratio 2021
Net income 2022
Net Debt 2022
P/E ratio 2022
Capi. / Sales 2021
Capi. / Sales 2022
Nbr of Employees
Codex DNA, Inc. is a synthetic biology company. The Company is focused on enabling researchers to build or write synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) that is ready to use in downstream synthetic biology enabled markets. Its synthetic biology solutions include the BioXp 3250 system, BioXp kits, BioXp portal, Benchtop reagent kits and Biofoundry services. Its BioXp system is an...
All news about CODEX DNA, INC.
09/20 CODEX DNA, INC.(NASDAQGS : DNAY) added to S&P TMI Index
09/16 CODEX DNA : Departure of Directors or Certain Officers; Election of Directors; Appointment..
09/16 CODEX DNA, INC. : Change in Directors or Principal Officers (form 8-K)
09/16 Codex DNA, Inc. Announces Departure of Timothy E. Cloutier as Senior Vice President, Ef..
09/01 Codex Dna Releases Full-Length Synthetic Genome for Highly Infectious Sars-Cov-2 Delta ..
08/11 CODEX DNA : Management's discussion and analysis of financial condition and results of ope..
08/10 CODEX DNA : Reports Second Quarter 2021 Financial Results (Form 8-K)
08/10 CODEX DNA, INC. : Results of Operations and Financial Condition, Financial Statements and ..
08/10 CODEX DNA : Earnings Flash (DNAY) CODEX DNA Reports Q2 Revenue $2.9M, vs. Street Est of $2..
08/10 CODEX DNA : Reports Second Quarter 2021 Financial Results
08/10 Codex DNA, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Month..
08/05 Codex DNA Announces Synthetic Biology Collaboration with U.S. Department of Agriculture..
08/03 Codex DNA to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021
07/21 CODEX DNA : Taps CleanCap mRNA Capping Technology From Maravai LifeSciences Unit TriLink
07/21 Codex DNA Announces Licensing and Supply Deal with TriLink Biotechnologies for CleanCap..
News in other languages on CODEX DNA, INC.
- No features available -
Analyst Recommendations on CODEX DNA, INC.
Number of Analysts
Last Close Price
Average target price
Spread / Average Target